NCT01180192

Brief Summary

In the aetiology of postpartum uterine atony, hypoxia is considered an important factor although some suggest that peripheral oxygen saturation is not influenced by oxygen inhalation in women during the first and second stages of labor. Enhancing oxygen delivery to myometrium through additional inhaled oxygen may improve uterine contractions. Therefore, it is reasonable to consider that oxygen inhalation may promote myometrial contraction and prevent postpartum haemorrhage (PPH) due to uterine atony. The tendency for the uterus to relax in women encountering respiratory problems immediately after cesarean section under general anaesthesia further strengthened this theory. The aim of this study was to evaluate the effectiveness of oxygen inhalation immediately after vaginal delivery on blood loss. The investigators hypothesized that inhaled oxygen helps to maintain uterine retraction during immediate postpartum period and hence reduces vaginal blood loss.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
450

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started May 2010

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2010

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 9, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 12, 2010

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2010

Completed
Last Updated

February 14, 2011

Status Verified

May 1, 2010

Enrollment Period

Same day

First QC Date

August 9, 2010

Last Update Submit

February 11, 2011

Conditions

Keywords

blood lossoxygen inhalation

Outcome Measures

Primary Outcomes (1)

  • The primary outcome was the amount of blood loss in the third and fourth stages of labor.

    The volume of blood loss was measured by weighing a sheet soaked from the end of the delivery to 2h after birth. Because it is important to collect the blood accurately, we used a specially designed operating sheet and an electronic scale to weigh all the material (with a 1 g deviation range). The quantity of blood (ml) = (weight of used materials - weight of materials prior to use)/1.05. Hemoglobin concentration was estimated on admission and 24 h after delivery

    two hours

Secondary Outcomes (1)

  • incidences of Postpartum Haemorrhage (PPH) (≥500 ml)

    two hours

Study Arms (1)

oxygen

EXPERIMENTAL
Drug: oxygen

Interventions

oxygenDRUG

either 8 L/minute O2 via face mask for 2 hours

Also known as: Women were randomized to receive either 8 L/minute O2 via face mask for 2 hours or breathed room air at the end of second stage of labor.
oxygen

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • gestational age between 37 and 42 weeks;
  • singleton pregnancy;
  • live fetus;
  • cephalic presentation;
  • neonatal birth weight of 2500-4500 g;
  • parity between one and five;
  • maternal age \< 35 years old;
  • vaginal birth

You may not qualify if:

  • blood pressure ≥ 140/90mmHg;
  • placenta previa;
  • placental abruption;
  • a history of any bleeding during pregnancy;
  • a history of curettage;
  • cesarean section or any uterine scar;
  • a history of postpartum hemorrhage;
  • polyhydramnios;
  • signs or symptoms of maternal infection;
  • known uterine anomalies;
  • history of any drug use during labor;
  • abnormal placentation;
  • coagulation defects;
  • instrumental deliveries;
  • hemoglobin concentration \< 8 g/dL;
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bakirkoy Women's and Children's Teaching Hospital

Istanbul, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Postpartum HemorrhageHemorrhage

Interventions

Oxygen

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPuerperal DisordersUterine HemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

ChalcogensElementsInorganic ChemicalsGases

Central Study Contacts

osman asıcıoğlu, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 9, 2010

First Posted

August 12, 2010

Study Start

May 1, 2010

Primary Completion

May 1, 2010

Study Completion

September 1, 2010

Last Updated

February 14, 2011

Record last verified: 2010-05

Locations